Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

USING ARTIFICIAL INTELLIGENCE FOR MASS SCREENING OF THE DIABETIC RETINOPATHY

NCT06112691 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.

NCT NCT06112691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06112691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
USING ARTIFICIAL INTELLIGENCE FOR MASS SCREENING OF THE DIABETIC RETINOPATHY
Lead sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
November 30, 2024
Enrollment
660 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy